Global ?-Propiolactone (Vaccine Inactivator) Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The global ?-Propiolactone (Vaccine Inactivator) market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “?-Propiolactone (Vaccine Inactivator) Industry Forecast” looks at past sales and reviews total world ?-Propiolactone (Vaccine Inactivator) sales in 2022, providing a comprehensive analysis by region and market sector of projected ?-Propiolactone (Vaccine Inactivator) sales for 2023 through 2029. With ?-Propiolactone (Vaccine Inactivator) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ?-Propiolactone (Vaccine Inactivator) industry.
This Insight Report provides a comprehensive analysis of the global ?-Propiolactone (Vaccine Inactivator) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on ?-Propiolactone (Vaccine Inactivator) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global ?-Propiolactone (Vaccine Inactivator) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ?-Propiolactone (Vaccine Inactivator) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ?-Propiolactone (Vaccine Inactivator).
United States market for ?-Propiolactone (Vaccine Inactivator) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for ?-Propiolactone (Vaccine Inactivator) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for ?-Propiolactone (Vaccine Inactivator) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key ?-Propiolactone (Vaccine Inactivator) players cover J&K Scientific, Ferak Berlin, Seebio, Fujifilm Wako, Thermo Scientific Chemicals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of ?-Propiolactone (Vaccine Inactivator) market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global ?-Propiolactone (Vaccine Inactivator) market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “?-Propiolactone (Vaccine Inactivator) Industry Forecast” looks at past sales and reviews total world ?-Propiolactone (Vaccine Inactivator) sales in 2022, providing a comprehensive analysis by region and market sector of projected ?-Propiolactone (Vaccine Inactivator) sales for 2023 through 2029. With ?-Propiolactone (Vaccine Inactivator) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ?-Propiolactone (Vaccine Inactivator) industry.
This Insight Report provides a comprehensive analysis of the global ?-Propiolactone (Vaccine Inactivator) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on ?-Propiolactone (Vaccine Inactivator) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global ?-Propiolactone (Vaccine Inactivator) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ?-Propiolactone (Vaccine Inactivator) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ?-Propiolactone (Vaccine Inactivator).
United States market for ?-Propiolactone (Vaccine Inactivator) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for ?-Propiolactone (Vaccine Inactivator) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for ?-Propiolactone (Vaccine Inactivator) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key ?-Propiolactone (Vaccine Inactivator) players cover J&K Scientific, Ferak Berlin, Seebio, Fujifilm Wako, Thermo Scientific Chemicals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of ?-Propiolactone (Vaccine Inactivator) market by product type, application, key players and key regions and countries.
Segmentation by Type:
- 97%
- 98%
- Others
- Human Vaccines
- Animal Vaccines
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- 97%
- 98%
- Others
- Human Vaccines
- Animal Vaccines
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- J&K Scientific
- Ferak Berlin
- Seebio
- Fujifilm Wako
- Thermo Scientific Chemicals
- CDH
- NoninBio
- Beijing Baiao Leibo Technology
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global ?-Propiolactone (Vaccine Inactivator) Market Size 2019-2030
2.1.2 ?-Propiolactone (Vaccine Inactivator) Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for ?-Propiolactone (Vaccine Inactivator) by Country/Region, 2019, 2023 & 2030
2.2 ?-Propiolactone (Vaccine Inactivator) Segment by Type
2.2.1 97%
2.2.2 98%
2.2.3 Others
2.3 ?-Propiolactone (Vaccine Inactivator) Market Size by Type
2.3.1 ?-Propiolactone (Vaccine Inactivator) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Type (2019-2024)
2.4 ?-Propiolactone (Vaccine Inactivator) Segment by Application
2.4.1 Human Vaccines
2.4.2 Animal Vaccines
2.5 ?-Propiolactone (Vaccine Inactivator) Market Size by Application
2.5.1 ?-Propiolactone (Vaccine Inactivator) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Application (2019-2024)
3 ?-PROPIOLACTONE (VACCINE INACTIVATOR) MARKET SIZE BY PLAYER
3.1 ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Player
3.1.1 Global ?-Propiolactone (Vaccine Inactivator) Revenue by Player (2019-2024)
3.1.2 Global ?-Propiolactone (Vaccine Inactivator) Revenue Market Share by Player (2019-2024)
3.2 Global ?-Propiolactone (Vaccine Inactivator) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ?-PROPIOLACTONE (VACCINE INACTIVATOR) BY REGION
4.1 ?-Propiolactone (Vaccine Inactivator) Market Size by Region (2019-2024)
4.2 Global ?-Propiolactone (Vaccine Inactivator) Annual Revenue by Country/Region (2019-2024)
4.3 Americas ?-Propiolactone (Vaccine Inactivator) Market Size Growth (2019-2024)
4.4 APAC ?-Propiolactone (Vaccine Inactivator) Market Size Growth (2019-2024)
4.5 Europe ?-Propiolactone (Vaccine Inactivator) Market Size Growth (2019-2024)
4.6 Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas ?-Propiolactone (Vaccine Inactivator) Market Size by Country (2019-2024)
5.2 Americas ?-Propiolactone (Vaccine Inactivator) Market Size by Type (2019-2024)
5.3 Americas ?-Propiolactone (Vaccine Inactivator) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC ?-Propiolactone (Vaccine Inactivator) Market Size by Region (2019-2024)
6.2 APAC ?-Propiolactone (Vaccine Inactivator) Market Size by Type (2019-2024)
6.3 APAC ?-Propiolactone (Vaccine Inactivator) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe ?-Propiolactone (Vaccine Inactivator) Market Size by Country (2019-2024)
7.2 Europe ?-Propiolactone (Vaccine Inactivator) Market Size by Type (2019-2024)
7.3 Europe ?-Propiolactone (Vaccine Inactivator) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa ?-Propiolactone (Vaccine Inactivator) by Region (2019-2024)
8.2 Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Market Size by Type (2019-2024)
8.3 Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ?-PROPIOLACTONE (VACCINE INACTIVATOR) MARKET FORECAST
10.1 Global ?-Propiolactone (Vaccine Inactivator) Forecast by Region (2025-2030)
10.1.1 Global ?-Propiolactone (Vaccine Inactivator) Forecast by Region (2025-2030)
10.1.2 Americas ?-Propiolactone (Vaccine Inactivator) Forecast
10.1.3 APAC ?-Propiolactone (Vaccine Inactivator) Forecast
10.1.4 Europe ?-Propiolactone (Vaccine Inactivator) Forecast
10.1.5 Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Forecast
10.2 Americas ?-Propiolactone (Vaccine Inactivator) Forecast by Country (2025-2030)
10.2.1 United States Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.2.2 Canada Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.2.3 Mexico Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.2.4 Brazil Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.3 APAC ?-Propiolactone (Vaccine Inactivator) Forecast by Region (2025-2030)
10.3.1 China ?-Propiolactone (Vaccine Inactivator) Market Forecast
10.3.2 Japan Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.3.3 Korea Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.3.4 Southeast Asia Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.3.5 India Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.3.6 Australia Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.4 Europe ?-Propiolactone (Vaccine Inactivator) Forecast by Country (2025-2030)
10.4.1 Germany Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.4.2 France Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.4.3 UK Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.4.4 Italy Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.4.5 Russia Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.5 Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Forecast by Region (2025-2030)
10.5.1 Egypt Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.5.2 South Africa Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.5.3 Israel Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.5.4 Turkey Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.6 Global ?-Propiolactone (Vaccine Inactivator) Forecast by Type (2025-2030)
10.7 Global ?-Propiolactone (Vaccine Inactivator) Forecast by Application (2025-2030)
10.7.1 GCC Countries Market ?-Propiolactone (Vaccine Inactivator) Forecast
11 KEY PLAYERS ANALYSIS
11.1 J&K Scientific
11.1.1 J&K Scientific Company Information
11.1.2 J&K Scientific ?-Propiolactone (Vaccine Inactivator) Product Offered
11.1.3 J&K Scientific ?-Propiolactone (Vaccine Inactivator) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 J&K Scientific Main Business Overview
11.1.5 J&K Scientific Latest Developments
11.2 Ferak Berlin
11.2.1 Ferak Berlin Company Information
11.2.2 Ferak Berlin ?-Propiolactone (Vaccine Inactivator) Product Offered
11.2.3 Ferak Berlin ?-Propiolactone (Vaccine Inactivator) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Ferak Berlin Main Business Overview
11.2.5 Ferak Berlin Latest Developments
11.3 Seebio
11.3.1 Seebio Company Information
11.3.2 Seebio ?-Propiolactone (Vaccine Inactivator) Product Offered
11.3.3 Seebio ?-Propiolactone (Vaccine Inactivator) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Seebio Main Business Overview
11.3.5 Seebio Latest Developments
11.4 Fujifilm Wako
11.4.1 Fujifilm Wako Company Information
11.4.2 Fujifilm Wako ?-Propiolactone (Vaccine Inactivator) Product Offered
11.4.3 Fujifilm Wako ?-Propiolactone (Vaccine Inactivator) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Fujifilm Wako Main Business Overview
11.4.5 Fujifilm Wako Latest Developments
11.5 Thermo Scientific Chemicals
11.5.1 Thermo Scientific Chemicals Company Information
11.5.2 Thermo Scientific Chemicals ?-Propiolactone (Vaccine Inactivator) Product Offered
11.5.3 Thermo Scientific Chemicals ?-Propiolactone (Vaccine Inactivator) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Thermo Scientific Chemicals Main Business Overview
11.5.5 Thermo Scientific Chemicals Latest Developments
11.6 CDH
11.6.1 CDH Company Information
11.6.2 CDH ?-Propiolactone (Vaccine Inactivator) Product Offered
11.6.3 CDH ?-Propiolactone (Vaccine Inactivator) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 CDH Main Business Overview
11.6.5 CDH Latest Developments
11.7 NoninBio
11.7.1 NoninBio Company Information
11.7.2 NoninBio ?-Propiolactone (Vaccine Inactivator) Product Offered
11.7.3 NoninBio ?-Propiolactone (Vaccine Inactivator) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 NoninBio Main Business Overview
11.7.5 NoninBio Latest Developments
11.8 Beijing Baiao Leibo Technology
11.8.1 Beijing Baiao Leibo Technology Company Information
11.8.2 Beijing Baiao Leibo Technology ?-Propiolactone (Vaccine Inactivator) Product Offered
11.8.3 Beijing Baiao Leibo Technology ?-Propiolactone (Vaccine Inactivator) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Beijing Baiao Leibo Technology Main Business Overview
11.8.5 Beijing Baiao Leibo Technology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
.
Table 1. ?-Propiolactone (Vaccine Inactivator) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. ?-Propiolactone (Vaccine Inactivator) Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 97%
Table 4. Major Players of 98%
Table 5. Major Players of Others
Table 6. ?-Propiolactone (Vaccine Inactivator) Market Size CAGR byType (2019 VS 2023 VS 2030) & ($ millions)
Table 7. Global ?-Propiolactone (Vaccine Inactivator) Market Size byType (2019-2024) & ($ millions)
Table 8. Global ?-Propiolactone (Vaccine Inactivator) Market Size Market Share byType (2019-2024)
Table 9. ?-Propiolactone (Vaccine Inactivator) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global ?-Propiolactone (Vaccine Inactivator) Market Size by Application (2019-2024) & ($ millions)
Table 11. Global ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Application (2019-2024)
Table 12. Global ?-Propiolactone (Vaccine Inactivator) Revenue by Player (2019-2024) & ($ millions)
Table 13. Global ?-Propiolactone (Vaccine Inactivator) Revenue Market Share by Player (2019-2024)
Table 14. ?-Propiolactone (Vaccine Inactivator) Key Players Head office and Products Offered
Table 15. ?-Propiolactone (Vaccine Inactivator) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global ?-Propiolactone (Vaccine Inactivator) Market Size by Region (2019-2024) & ($ millions)
Table 19. Global ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Region (2019-2024)
Table 20. Global ?-Propiolactone (Vaccine Inactivator) Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global ?-Propiolactone (Vaccine Inactivator) Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas ?-Propiolactone (Vaccine Inactivator) Market Size by Country (2019-2024) & ($ millions)
Table 23. Americas ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Country (2019-2024)
Table 24. Americas ?-Propiolactone (Vaccine Inactivator) Market Size byType (2019-2024) & ($ millions)
Table 25. Americas ?-Propiolactone (Vaccine Inactivator) Market Size Market Share byType (2019-2024)
Table 26. Americas ?-Propiolactone (Vaccine Inactivator) Market Size by Application (2019-2024) & ($ millions)
Table 27. Americas ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Application (2019-2024)
Table 28. APAC ?-Propiolactone (Vaccine Inactivator) Market Size by Region (2019-2024) & ($ millions)
Table 29. APAC ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Region (2019-2024)
Table 30. APAC ?-Propiolactone (Vaccine Inactivator) Market Size byType (2019-2024) & ($ millions)
Table 31. APAC ?-Propiolactone (Vaccine Inactivator) Market Size by Application (2019-2024) & ($ millions)
Table 32. Europe ?-Propiolactone (Vaccine Inactivator) Market Size by Country (2019-2024) & ($ millions)
Table 33. Europe ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Country (2019-2024)
Table 34. Europe ?-Propiolactone (Vaccine Inactivator) Market Size byType (2019-2024) & ($ millions)
Table 35. Europe ?-Propiolactone (Vaccine Inactivator) Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Market Size byType (2019-2024) & ($ millions)
Table 38. Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of ?-Propiolactone (Vaccine Inactivator)
Table 40. Key Market Challenges & Risks of ?-Propiolactone (Vaccine Inactivator)
Table 41. Key IndustryTrends of ?-Propiolactone (Vaccine Inactivator)
Table 42. Global ?-Propiolactone (Vaccine Inactivator) Market SizeForecast by Region (2025-2030) & ($ millions)
Table 43. Global ?-Propiolactone (Vaccine Inactivator) Market Size Market ShareForecast by Region (2025-2030)
Table 44. Global ?-Propiolactone (Vaccine Inactivator) Market SizeForecast byType (2025-2030) & ($ millions)
Table 45. Global ?-Propiolactone (Vaccine Inactivator) Market SizeForecast by Application (2025-2030) & ($ millions)
Table 46. J&K Scientific Details, CompanyType, ?-Propiolactone (Vaccine Inactivator) Area Served and Its Competitors
Table 47. J&K Scientific ?-Propiolactone (Vaccine Inactivator) Product Offered
Table 48. J&K Scientific ?-Propiolactone (Vaccine Inactivator) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. J&K Scientific Main Business
Table 50. J&K Scientific Latest Developments
Table 51.Ferak Berlin Details, CompanyType, ?-Propiolactone (Vaccine Inactivator) Area Served and Its Competitors
Table 52.Ferak Berlin ?-Propiolactone (Vaccine Inactivator) Product Offered
Table 53.Ferak Berlin ?-Propiolactone (Vaccine Inactivator) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54.Ferak Berlin Main Business
Table 55.Ferak Berlin Latest Developments
Table 56. Seebio Details, CompanyType, ?-Propiolactone (Vaccine Inactivator) Area Served and Its Competitors
Table 57. Seebio ?-Propiolactone (Vaccine Inactivator) Product Offered
Table 58. Seebio ?-Propiolactone (Vaccine Inactivator) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Seebio Main Business
Table 60. Seebio Latest Developments
Table 61.Fujifilm Wako Details, CompanyType, ?-Propiolactone (Vaccine Inactivator) Area Served and Its Competitors
Table 62.Fujifilm Wako ?-Propiolactone (Vaccine Inactivator) Product Offered
Table 63.Fujifilm Wako ?-Propiolactone (Vaccine Inactivator) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64.Fujifilm Wako Main Business
Table 65.Fujifilm Wako Latest Developments
Table 66.Thermo Scientific Chemicals Details, CompanyType, ?-Propiolactone (Vaccine Inactivator) Area Served and Its Competitors
Table 67.Thermo Scientific Chemicals ?-Propiolactone (Vaccine Inactivator) Product Offered
Table 68.Thermo Scientific Chemicals ?-Propiolactone (Vaccine Inactivator) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69.Thermo Scientific Chemicals Main Business
Table 70.Thermo Scientific Chemicals Latest Developments
Table 71. CDH Details, CompanyType, ?-Propiolactone (Vaccine Inactivator) Area Served and Its Competitors
Table 72. CDH ?-Propiolactone (Vaccine Inactivator) Product Offered
Table 73. CDH ?-Propiolactone (Vaccine Inactivator) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. CDH Main Business
Table 75. CDH Latest Developments
Table 76. NoninBio Details, CompanyType, ?-Propiolactone (Vaccine Inactivator) Area Served and Its Competitors
Table 77. NoninBio ?-Propiolactone (Vaccine Inactivator) Product Offered
Table 78. NoninBio ?-Propiolactone (Vaccine Inactivator) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. NoninBio Main Business
Table 80. NoninBio Latest Developments
Table 81. Beijing Baiao LeiboTechnology Details, CompanyType, ?-Propiolactone (Vaccine Inactivator) Area Served and Its Competitors
Table 82. Beijing Baiao LeiboTechnology ?-Propiolactone (Vaccine Inactivator) Product Offered
Table 83. Beijing Baiao LeiboTechnology ?-Propiolactone (Vaccine Inactivator) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Beijing Baiao LeiboTechnology Main Business
Table 85. Beijing Baiao LeiboTechnology Latest Developments
LIST OFFIGURES
.
Figure 1. ?-Propiolactone (Vaccine Inactivator) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global ?-Propiolactone (Vaccine Inactivator) Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. ?-Propiolactone (Vaccine Inactivator) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. ?-Propiolactone (Vaccine Inactivator) Sales Market Share by Country/Region (2023)
Figure 8. ?-Propiolactone (Vaccine Inactivator) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global ?-Propiolactone (Vaccine Inactivator) Market Size Market Share byType in 2023
Figure 10. ?-Propiolactone (Vaccine Inactivator) in Human Vaccines
Figure 11. Global ?-Propiolactone (Vaccine Inactivator) Market: Human Vaccines (2019-2024) & ($ millions)
Figure 12. ?-Propiolactone (Vaccine Inactivator) in Animal Vaccines
Figure 13. Global ?-Propiolactone (Vaccine Inactivator) Market: Animal Vaccines (2019-2024) & ($ millions)
Figure 14. Global ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Application in 2023
Figure 15. Global ?-Propiolactone (Vaccine Inactivator) Revenue Market Share by Player in 2023
Figure 16. Global ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Region (2019-2024)
Figure 17. Americas ?-Propiolactone (Vaccine Inactivator) Market Size 2019-2024 ($ millions)
Figure 18. APAC ?-Propiolactone (Vaccine Inactivator) Market Size 2019-2024 ($ millions)
Figure 19. Europe ?-Propiolactone (Vaccine Inactivator) Market Size 2019-2024 ($ millions)
Figure 20. Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Market Size 2019-2024 ($ millions)
Figure 21. Americas ?-Propiolactone (Vaccine Inactivator) Value Market Share by Country in 2023
Figure 22. United States ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 23. Canada ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 24. Mexico ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 25. Brazil ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 26. APAC ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Region in 2023
Figure 27. APAC ?-Propiolactone (Vaccine Inactivator) Market Size Market Share byType (2019-2024)
Figure 28. APAC ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Application (2019-2024)
Figure 29. China ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 30. Japan ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 31. South Korea ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 32. Southeast Asia ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 33. India ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 34. Australia ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 35. Europe ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Country in 2023
Figure 36. Europe ?-Propiolactone (Vaccine Inactivator) Market Size Market Share byType (2019-2024)
Figure 37. Europe ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Application (2019-2024)
Figure 38. Germany ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 39.France ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 40. UK ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 41. Italy ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 42. Russia ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 43. Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Market Size Market Share byType (2019-2024)
Figure 45. Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Application (2019-2024)
Figure 46. Egypt ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 47. South Africa ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 48. Israel ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 49.Turkey ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 50. GCC Countries ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 51. Americas ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 52. APAC ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 53. Europe ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 54. Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 55. United States ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 56. Canada ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 57. Mexico ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 58. Brazil ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 59. China ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 60. Japan ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 61. Korea ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 62. Southeast Asia ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 63. India ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 64. Australia ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 65. Germany ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 66.France ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 67. UK ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 68. Italy ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 69. Russia ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 70. Egypt ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 71. South Africa ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 72. Israel ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 73.Turkey ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 74. GCC Countries ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 75. Global ?-Propiolactone (Vaccine Inactivator) Market Size Market ShareForecast byType (2025-2030)
Figure 76. Global ?-Propiolactone (Vaccine Inactivator) Market Size Market ShareForecast by Application (2025-2030)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global ?-Propiolactone (Vaccine Inactivator) Market Size 2019-2030
2.1.2 ?-Propiolactone (Vaccine Inactivator) Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for ?-Propiolactone (Vaccine Inactivator) by Country/Region, 2019, 2023 & 2030
2.2 ?-Propiolactone (Vaccine Inactivator) Segment by Type
2.2.1 97%
2.2.2 98%
2.2.3 Others
2.3 ?-Propiolactone (Vaccine Inactivator) Market Size by Type
2.3.1 ?-Propiolactone (Vaccine Inactivator) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Type (2019-2024)
2.4 ?-Propiolactone (Vaccine Inactivator) Segment by Application
2.4.1 Human Vaccines
2.4.2 Animal Vaccines
2.5 ?-Propiolactone (Vaccine Inactivator) Market Size by Application
2.5.1 ?-Propiolactone (Vaccine Inactivator) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Application (2019-2024)
3 ?-PROPIOLACTONE (VACCINE INACTIVATOR) MARKET SIZE BY PLAYER
3.1 ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Player
3.1.1 Global ?-Propiolactone (Vaccine Inactivator) Revenue by Player (2019-2024)
3.1.2 Global ?-Propiolactone (Vaccine Inactivator) Revenue Market Share by Player (2019-2024)
3.2 Global ?-Propiolactone (Vaccine Inactivator) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ?-PROPIOLACTONE (VACCINE INACTIVATOR) BY REGION
4.1 ?-Propiolactone (Vaccine Inactivator) Market Size by Region (2019-2024)
4.2 Global ?-Propiolactone (Vaccine Inactivator) Annual Revenue by Country/Region (2019-2024)
4.3 Americas ?-Propiolactone (Vaccine Inactivator) Market Size Growth (2019-2024)
4.4 APAC ?-Propiolactone (Vaccine Inactivator) Market Size Growth (2019-2024)
4.5 Europe ?-Propiolactone (Vaccine Inactivator) Market Size Growth (2019-2024)
4.6 Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas ?-Propiolactone (Vaccine Inactivator) Market Size by Country (2019-2024)
5.2 Americas ?-Propiolactone (Vaccine Inactivator) Market Size by Type (2019-2024)
5.3 Americas ?-Propiolactone (Vaccine Inactivator) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC ?-Propiolactone (Vaccine Inactivator) Market Size by Region (2019-2024)
6.2 APAC ?-Propiolactone (Vaccine Inactivator) Market Size by Type (2019-2024)
6.3 APAC ?-Propiolactone (Vaccine Inactivator) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe ?-Propiolactone (Vaccine Inactivator) Market Size by Country (2019-2024)
7.2 Europe ?-Propiolactone (Vaccine Inactivator) Market Size by Type (2019-2024)
7.3 Europe ?-Propiolactone (Vaccine Inactivator) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa ?-Propiolactone (Vaccine Inactivator) by Region (2019-2024)
8.2 Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Market Size by Type (2019-2024)
8.3 Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ?-PROPIOLACTONE (VACCINE INACTIVATOR) MARKET FORECAST
10.1 Global ?-Propiolactone (Vaccine Inactivator) Forecast by Region (2025-2030)
10.1.1 Global ?-Propiolactone (Vaccine Inactivator) Forecast by Region (2025-2030)
10.1.2 Americas ?-Propiolactone (Vaccine Inactivator) Forecast
10.1.3 APAC ?-Propiolactone (Vaccine Inactivator) Forecast
10.1.4 Europe ?-Propiolactone (Vaccine Inactivator) Forecast
10.1.5 Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Forecast
10.2 Americas ?-Propiolactone (Vaccine Inactivator) Forecast by Country (2025-2030)
10.2.1 United States Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.2.2 Canada Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.2.3 Mexico Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.2.4 Brazil Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.3 APAC ?-Propiolactone (Vaccine Inactivator) Forecast by Region (2025-2030)
10.3.1 China ?-Propiolactone (Vaccine Inactivator) Market Forecast
10.3.2 Japan Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.3.3 Korea Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.3.4 Southeast Asia Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.3.5 India Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.3.6 Australia Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.4 Europe ?-Propiolactone (Vaccine Inactivator) Forecast by Country (2025-2030)
10.4.1 Germany Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.4.2 France Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.4.3 UK Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.4.4 Italy Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.4.5 Russia Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.5 Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Forecast by Region (2025-2030)
10.5.1 Egypt Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.5.2 South Africa Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.5.3 Israel Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.5.4 Turkey Market ?-Propiolactone (Vaccine Inactivator) Forecast
10.6 Global ?-Propiolactone (Vaccine Inactivator) Forecast by Type (2025-2030)
10.7 Global ?-Propiolactone (Vaccine Inactivator) Forecast by Application (2025-2030)
10.7.1 GCC Countries Market ?-Propiolactone (Vaccine Inactivator) Forecast
11 KEY PLAYERS ANALYSIS
11.1 J&K Scientific
11.1.1 J&K Scientific Company Information
11.1.2 J&K Scientific ?-Propiolactone (Vaccine Inactivator) Product Offered
11.1.3 J&K Scientific ?-Propiolactone (Vaccine Inactivator) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 J&K Scientific Main Business Overview
11.1.5 J&K Scientific Latest Developments
11.2 Ferak Berlin
11.2.1 Ferak Berlin Company Information
11.2.2 Ferak Berlin ?-Propiolactone (Vaccine Inactivator) Product Offered
11.2.3 Ferak Berlin ?-Propiolactone (Vaccine Inactivator) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Ferak Berlin Main Business Overview
11.2.5 Ferak Berlin Latest Developments
11.3 Seebio
11.3.1 Seebio Company Information
11.3.2 Seebio ?-Propiolactone (Vaccine Inactivator) Product Offered
11.3.3 Seebio ?-Propiolactone (Vaccine Inactivator) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Seebio Main Business Overview
11.3.5 Seebio Latest Developments
11.4 Fujifilm Wako
11.4.1 Fujifilm Wako Company Information
11.4.2 Fujifilm Wako ?-Propiolactone (Vaccine Inactivator) Product Offered
11.4.3 Fujifilm Wako ?-Propiolactone (Vaccine Inactivator) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Fujifilm Wako Main Business Overview
11.4.5 Fujifilm Wako Latest Developments
11.5 Thermo Scientific Chemicals
11.5.1 Thermo Scientific Chemicals Company Information
11.5.2 Thermo Scientific Chemicals ?-Propiolactone (Vaccine Inactivator) Product Offered
11.5.3 Thermo Scientific Chemicals ?-Propiolactone (Vaccine Inactivator) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Thermo Scientific Chemicals Main Business Overview
11.5.5 Thermo Scientific Chemicals Latest Developments
11.6 CDH
11.6.1 CDH Company Information
11.6.2 CDH ?-Propiolactone (Vaccine Inactivator) Product Offered
11.6.3 CDH ?-Propiolactone (Vaccine Inactivator) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 CDH Main Business Overview
11.6.5 CDH Latest Developments
11.7 NoninBio
11.7.1 NoninBio Company Information
11.7.2 NoninBio ?-Propiolactone (Vaccine Inactivator) Product Offered
11.7.3 NoninBio ?-Propiolactone (Vaccine Inactivator) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 NoninBio Main Business Overview
11.7.5 NoninBio Latest Developments
11.8 Beijing Baiao Leibo Technology
11.8.1 Beijing Baiao Leibo Technology Company Information
11.8.2 Beijing Baiao Leibo Technology ?-Propiolactone (Vaccine Inactivator) Product Offered
11.8.3 Beijing Baiao Leibo Technology ?-Propiolactone (Vaccine Inactivator) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Beijing Baiao Leibo Technology Main Business Overview
11.8.5 Beijing Baiao Leibo Technology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
.
Table 1. ?-Propiolactone (Vaccine Inactivator) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. ?-Propiolactone (Vaccine Inactivator) Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 97%
Table 4. Major Players of 98%
Table 5. Major Players of Others
Table 6. ?-Propiolactone (Vaccine Inactivator) Market Size CAGR byType (2019 VS 2023 VS 2030) & ($ millions)
Table 7. Global ?-Propiolactone (Vaccine Inactivator) Market Size byType (2019-2024) & ($ millions)
Table 8. Global ?-Propiolactone (Vaccine Inactivator) Market Size Market Share byType (2019-2024)
Table 9. ?-Propiolactone (Vaccine Inactivator) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global ?-Propiolactone (Vaccine Inactivator) Market Size by Application (2019-2024) & ($ millions)
Table 11. Global ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Application (2019-2024)
Table 12. Global ?-Propiolactone (Vaccine Inactivator) Revenue by Player (2019-2024) & ($ millions)
Table 13. Global ?-Propiolactone (Vaccine Inactivator) Revenue Market Share by Player (2019-2024)
Table 14. ?-Propiolactone (Vaccine Inactivator) Key Players Head office and Products Offered
Table 15. ?-Propiolactone (Vaccine Inactivator) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global ?-Propiolactone (Vaccine Inactivator) Market Size by Region (2019-2024) & ($ millions)
Table 19. Global ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Region (2019-2024)
Table 20. Global ?-Propiolactone (Vaccine Inactivator) Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global ?-Propiolactone (Vaccine Inactivator) Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas ?-Propiolactone (Vaccine Inactivator) Market Size by Country (2019-2024) & ($ millions)
Table 23. Americas ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Country (2019-2024)
Table 24. Americas ?-Propiolactone (Vaccine Inactivator) Market Size byType (2019-2024) & ($ millions)
Table 25. Americas ?-Propiolactone (Vaccine Inactivator) Market Size Market Share byType (2019-2024)
Table 26. Americas ?-Propiolactone (Vaccine Inactivator) Market Size by Application (2019-2024) & ($ millions)
Table 27. Americas ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Application (2019-2024)
Table 28. APAC ?-Propiolactone (Vaccine Inactivator) Market Size by Region (2019-2024) & ($ millions)
Table 29. APAC ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Region (2019-2024)
Table 30. APAC ?-Propiolactone (Vaccine Inactivator) Market Size byType (2019-2024) & ($ millions)
Table 31. APAC ?-Propiolactone (Vaccine Inactivator) Market Size by Application (2019-2024) & ($ millions)
Table 32. Europe ?-Propiolactone (Vaccine Inactivator) Market Size by Country (2019-2024) & ($ millions)
Table 33. Europe ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Country (2019-2024)
Table 34. Europe ?-Propiolactone (Vaccine Inactivator) Market Size byType (2019-2024) & ($ millions)
Table 35. Europe ?-Propiolactone (Vaccine Inactivator) Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Market Size byType (2019-2024) & ($ millions)
Table 38. Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of ?-Propiolactone (Vaccine Inactivator)
Table 40. Key Market Challenges & Risks of ?-Propiolactone (Vaccine Inactivator)
Table 41. Key IndustryTrends of ?-Propiolactone (Vaccine Inactivator)
Table 42. Global ?-Propiolactone (Vaccine Inactivator) Market SizeForecast by Region (2025-2030) & ($ millions)
Table 43. Global ?-Propiolactone (Vaccine Inactivator) Market Size Market ShareForecast by Region (2025-2030)
Table 44. Global ?-Propiolactone (Vaccine Inactivator) Market SizeForecast byType (2025-2030) & ($ millions)
Table 45. Global ?-Propiolactone (Vaccine Inactivator) Market SizeForecast by Application (2025-2030) & ($ millions)
Table 46. J&K Scientific Details, CompanyType, ?-Propiolactone (Vaccine Inactivator) Area Served and Its Competitors
Table 47. J&K Scientific ?-Propiolactone (Vaccine Inactivator) Product Offered
Table 48. J&K Scientific ?-Propiolactone (Vaccine Inactivator) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. J&K Scientific Main Business
Table 50. J&K Scientific Latest Developments
Table 51.Ferak Berlin Details, CompanyType, ?-Propiolactone (Vaccine Inactivator) Area Served and Its Competitors
Table 52.Ferak Berlin ?-Propiolactone (Vaccine Inactivator) Product Offered
Table 53.Ferak Berlin ?-Propiolactone (Vaccine Inactivator) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54.Ferak Berlin Main Business
Table 55.Ferak Berlin Latest Developments
Table 56. Seebio Details, CompanyType, ?-Propiolactone (Vaccine Inactivator) Area Served and Its Competitors
Table 57. Seebio ?-Propiolactone (Vaccine Inactivator) Product Offered
Table 58. Seebio ?-Propiolactone (Vaccine Inactivator) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Seebio Main Business
Table 60. Seebio Latest Developments
Table 61.Fujifilm Wako Details, CompanyType, ?-Propiolactone (Vaccine Inactivator) Area Served and Its Competitors
Table 62.Fujifilm Wako ?-Propiolactone (Vaccine Inactivator) Product Offered
Table 63.Fujifilm Wako ?-Propiolactone (Vaccine Inactivator) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64.Fujifilm Wako Main Business
Table 65.Fujifilm Wako Latest Developments
Table 66.Thermo Scientific Chemicals Details, CompanyType, ?-Propiolactone (Vaccine Inactivator) Area Served and Its Competitors
Table 67.Thermo Scientific Chemicals ?-Propiolactone (Vaccine Inactivator) Product Offered
Table 68.Thermo Scientific Chemicals ?-Propiolactone (Vaccine Inactivator) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69.Thermo Scientific Chemicals Main Business
Table 70.Thermo Scientific Chemicals Latest Developments
Table 71. CDH Details, CompanyType, ?-Propiolactone (Vaccine Inactivator) Area Served and Its Competitors
Table 72. CDH ?-Propiolactone (Vaccine Inactivator) Product Offered
Table 73. CDH ?-Propiolactone (Vaccine Inactivator) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. CDH Main Business
Table 75. CDH Latest Developments
Table 76. NoninBio Details, CompanyType, ?-Propiolactone (Vaccine Inactivator) Area Served and Its Competitors
Table 77. NoninBio ?-Propiolactone (Vaccine Inactivator) Product Offered
Table 78. NoninBio ?-Propiolactone (Vaccine Inactivator) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. NoninBio Main Business
Table 80. NoninBio Latest Developments
Table 81. Beijing Baiao LeiboTechnology Details, CompanyType, ?-Propiolactone (Vaccine Inactivator) Area Served and Its Competitors
Table 82. Beijing Baiao LeiboTechnology ?-Propiolactone (Vaccine Inactivator) Product Offered
Table 83. Beijing Baiao LeiboTechnology ?-Propiolactone (Vaccine Inactivator) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Beijing Baiao LeiboTechnology Main Business
Table 85. Beijing Baiao LeiboTechnology Latest Developments
LIST OFFIGURES
.
Figure 1. ?-Propiolactone (Vaccine Inactivator) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global ?-Propiolactone (Vaccine Inactivator) Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. ?-Propiolactone (Vaccine Inactivator) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. ?-Propiolactone (Vaccine Inactivator) Sales Market Share by Country/Region (2023)
Figure 8. ?-Propiolactone (Vaccine Inactivator) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global ?-Propiolactone (Vaccine Inactivator) Market Size Market Share byType in 2023
Figure 10. ?-Propiolactone (Vaccine Inactivator) in Human Vaccines
Figure 11. Global ?-Propiolactone (Vaccine Inactivator) Market: Human Vaccines (2019-2024) & ($ millions)
Figure 12. ?-Propiolactone (Vaccine Inactivator) in Animal Vaccines
Figure 13. Global ?-Propiolactone (Vaccine Inactivator) Market: Animal Vaccines (2019-2024) & ($ millions)
Figure 14. Global ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Application in 2023
Figure 15. Global ?-Propiolactone (Vaccine Inactivator) Revenue Market Share by Player in 2023
Figure 16. Global ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Region (2019-2024)
Figure 17. Americas ?-Propiolactone (Vaccine Inactivator) Market Size 2019-2024 ($ millions)
Figure 18. APAC ?-Propiolactone (Vaccine Inactivator) Market Size 2019-2024 ($ millions)
Figure 19. Europe ?-Propiolactone (Vaccine Inactivator) Market Size 2019-2024 ($ millions)
Figure 20. Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Market Size 2019-2024 ($ millions)
Figure 21. Americas ?-Propiolactone (Vaccine Inactivator) Value Market Share by Country in 2023
Figure 22. United States ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 23. Canada ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 24. Mexico ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 25. Brazil ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 26. APAC ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Region in 2023
Figure 27. APAC ?-Propiolactone (Vaccine Inactivator) Market Size Market Share byType (2019-2024)
Figure 28. APAC ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Application (2019-2024)
Figure 29. China ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 30. Japan ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 31. South Korea ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 32. Southeast Asia ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 33. India ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 34. Australia ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 35. Europe ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Country in 2023
Figure 36. Europe ?-Propiolactone (Vaccine Inactivator) Market Size Market Share byType (2019-2024)
Figure 37. Europe ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Application (2019-2024)
Figure 38. Germany ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 39.France ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 40. UK ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 41. Italy ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 42. Russia ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 43. Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Market Size Market Share byType (2019-2024)
Figure 45. Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Market Size Market Share by Application (2019-2024)
Figure 46. Egypt ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 47. South Africa ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 48. Israel ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 49.Turkey ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 50. GCC Countries ?-Propiolactone (Vaccine Inactivator) Market Size Growth 2019-2024 ($ millions)
Figure 51. Americas ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 52. APAC ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 53. Europe ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 54. Middle East & Africa ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 55. United States ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 56. Canada ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 57. Mexico ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 58. Brazil ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 59. China ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 60. Japan ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 61. Korea ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 62. Southeast Asia ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 63. India ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 64. Australia ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 65. Germany ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 66.France ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 67. UK ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 68. Italy ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 69. Russia ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 70. Egypt ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 71. South Africa ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 72. Israel ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 73.Turkey ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 74. GCC Countries ?-Propiolactone (Vaccine Inactivator) Market Size 2025-2030 ($ millions)
Figure 75. Global ?-Propiolactone (Vaccine Inactivator) Market Size Market ShareForecast byType (2025-2030)
Figure 76. Global ?-Propiolactone (Vaccine Inactivator) Market Size Market ShareForecast by Application (2025-2030)
